Antiphospholipid syndrome (APS) is primarily considered to be an autoimmune pathological
condition that is also referred to as" Hughes syndrome". It is characterized by arterial and/or …

The antiphospholipid (Hughes) syndrome (APS) is characterized by arterial and/or venous
thrombosis and pregnancy morbidity in the presence of anticardiolipin antibodies and/or …

Antiphospholipid syndrome (APS) or Hughes syndrome is an acquired thromboinflammatory
disorder. Clinical criteria of APS diagnosis are large-and small-vessel thrombosis as well as …

Antiphospholipid syndrome (APS) is an autoimmune antibody-mediated condition
characterized by thrombotic events and/or pregnancy morbidity in association with persistent …

Antiphospholipid syndrome (APS) is a common autoimmune pro-thrombotic condition
characterised by thrombosis and pregnancy morbidity. There are a broad range of …

Background Anti-phospholipids syndrome (APS) is considered a non inflammatory auto-
immune disease with a significant thrombophilic risk with varied clinical manifestations. The …

Neurological manifestations or disorders associated with the central nervous system are
among the most common and important clinical characteristics of antiphospholipid …

Antiphospholipid syndrome (APS) is a prothrombotic autoimmune disease with
heterogeneous clinicopathological manifestations and is a well-established cause of acute …

The antiphospholipid (Hughes) syndrome (APS), the most frequent type of acquired
thrombophilia, is defined by the occurrence of thrombosis or pregnancy morbidity in the …

The antiphospholipid syndrome (APS) is defined by the association of high titers of
antiphospholipid antibodies (aPLs) with thrombotic events and/or obstetrical problems. APS …